DR5 (Conatumumab) Recombinant Monoclonal Antibody

• Gene Aliases:

  Rotein antibody; Apoptosis inducing protein TRICK2A/2B antibody; Apoptosis inducing receptor TRAIL R2 antibody; CD262 antibody; CD262 antigen antibody; Cytotoxic TRAIL receptor 2 antibody; Death domain containing receptor for TRAIL/Apo 2L antibody; Death receptor 5 antibody; DR5 antibody; KILLER antibody; KILLER/DR5 antibody; OTTHUMP00000123492 antibody; OTTHUMP00000123493 antibody; p53 regulated DNA damage inducible cell death receptor (killer) antibody; TNF related apoptosis inducing ligand receptor 2 antibody; TNF-related apoptosis-inducing ligand receptor 2 antibody; TNFRSF10B antibody; TR10B_HUMAN antibody; TRAIL R2 antibody; TRAIL receptor 2 antibody; TRAIL-R2 antibody; TRAILR2 antibody; TRICK2 antibody; TRICK2A antibody; TRICK2B antibody; TRICKB antibody; Tumor necrosis factor receptor like protein ZTNFR9 antibody; Tumor necrosis factor receptor superfamily member 10B antibody; Tumor necrosis factor receptor superfamily; member 10b antibody; ZTNFR9 antibody; Conatumumab

• UniProt:

  O14763

• Antigen Species:

  Human

• Reactivity:

  Human

• Target Antigen:

  Recombinant Human DR5 protein

• Target:

  TNFRSF10B

• Clonality:

  Monoclonal

• Conjugation:

  Non-conjugated

• Field of Research:

  Cancer; Cardiovascular; Cell biology; Signal transduction

• Purification Method:

  Affinity-chromatography

• Form:

  Liquid

• Storage Conditions:

  Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

• Antibody Type:

  Recombinant Antibody

• Clone ID:

  1D10

• Tested Applications:

  ELISA; Recommended dilution: ELISA:1:5000-1:50000

• Isotype:

  IgG1